CareTrust REIT, Inc. owns, acquires, develops and leases healthcare-related real estate, including skilled nursing facilities, seniors housing and care homes. The self-administered REIT generates rental revenue through long-term net-leased properties operated by healthcare providers, with a portfolio spanning the United States and the United Kingdom.
Company news commonly covers operating results, Normalized FFO and FAD guidance, dividend declarations, portfolio acquisitions, sale-leaseback investments, secured operator loans, tenant relationships and credit ratings. Updates also address balance-sheet capacity, debt maturities, revolving credit and common-equity funding programs used to support healthcare real estate growth.
CareTrust REIT (NYSE: CTRE) priced a forward-basis public stock offering for gross proceeds of approximately $637.5 million.
The offering covers 17,000,000 shares, with a 30-day underwriter option for up to 2,550,000 additional shares. Closing is expected on November 13, 2026, subject to customary closing conditions. CareTrust entered into forward sale agreements with Bank of America and Morgan Stanley or their respective affiliates. The company will receive no initial proceeds from their share sales and expects physical settlement within approximately one year from the prospectus supplement date, subject to its right to elect cash or net share settlement.
CareTrust REIT (NYSE: CTRE) has launched an underwritten public offering of 17,000,000 common shares connected to planned forward sale agreements. The offering is subject to market and other conditions. Underwriters are expected to receive a 30-day option to purchase up to an additional 2,550,000 shares.
The company expects to enter into forward sale agreements with Bank of America and Morgan Stanley or their affiliates, which are expected to borrow shares for sale to the underwriters. CareTrust will receive no initial proceeds from those sales. It expects physical settlement within approximately one year from the offering prospectus supplement date, subject to its right to elect cash or net share settlement.
CareTrust REIT (NYSE:CTRE) reported third-quarter 2026 normalized funds from operations of $0.54 per diluted share, up 20% year over year. Net income attributable to CareTrust was $83.7 million, with diluted earnings unchanged at $0.35. Revenue rose to $176.360 million from $132.444 million.
Quarterly investments totaled $739.5 million at an 8.3% blended stabilized yield. After quarter-end, CareTrust acquired 23 LNT care homes for £552 million, excluding transaction costs; another 22 homes are expected through 2027 for £528 million. Year-to-date investments reached approximately $2.9 billion at an 8.1% yield. A new $700 million term loan matures in 2032, and the revolving credit facility expanded to $2.0 billion.
CareTrust raised its 2026 guidance midpoints, projecting normalized funds from operations of approximately $2.08–$2.09 per share and normalized funds available for distribution of approximately $2.04–$2.05 per share.
CareTrust REIT (CTRE) plans to release its third-quarter 2026 financial results after U.S. markets close on November 5, 2026. Management will host a conference call on November 6, 2026, at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss the results and other current matters. A webcast will be available through the company’s investor website, with a recording available for approximately 30 days following the call.
CareTrust REIT (NYSE: CTRE) released its sixth annual Corporate Sustainability Report, covering sustainability and corporate responsibility initiatives during 2025.
The report describes its approach across skilled nursing, UK care homes and its emerging seniors housing operating portfolio. Highlights include an updated environmental, social and governance policy, climate-risk assessments at newly acquired properties, expanded sustainability provisions in new leases and support for renewable energy installations at seven UK properties. CareTrust also reported 100% employee retention and doubled professional headcount. The report is available in the corporate responsibility section of its investor website.
CareTrust REIT (CTRE) signed a definitive agreement with LNT Care Developments to acquire 45 UK care homes for approximately £1.1 billion. The initial tranche totals approximately £576 million, excluding transaction costs, for 24 homes; one home's closing remains subject to regulatory approval anticipated in October 2026. The first closing occurred October 1. The remaining 21 homes cost approximately £504 million, with acquisitions dependent on completion and regulatory approvals anticipated throughout 2027.
Crystal Care subsidiaries will initially lease the homes before an intended transition to a senior housing operating portfolio. CareTrust expects lease-up earnings accretion and a mid- to high-7% pre-tax yield in the first operating-portfolio year. It also closed approximately $488 million of other investments and raised 2026 guidance: net income of approximately $1.54–$1.57 per share and normalized funds from operations of approximately $2.06–$2.09 per share.
CareTrust REIT (CTRE)/b) declared a quarterly common stock cash dividend of $0.39 per share. The dividend will be paid to stockholders of record as of the close of business on September 30, 2026, and is expected to be paid on or about October 15, 2026.CareTrust REIT is a publicly traded real estate investment trust focused on owning, acquiring, developing and leasing skilled nursing, senior housing and other healthcare-related properties in the United States and United Kingdom.
CareTrust REIT (CTRE) acquired a southwest skilled nursing portfolio for a $400 million purchase price effective September 1, 2026.
The portfolio includes 2,622 licensed skilled nursing beds, structured as a triple-net lease to the existing operator under a long-term lease with inflation-based rent escalators and multiple renewal options. The off-market transaction was completed via a joint venture in which CareTrust invested approximately $380 million, funded with cash on hand and proceeds from settled equity forward contracts.
The company expects a stabilized yield of about 8.6% from this portfolio. Third quarter-to-date closed investments total approximately $710 million, and 2026 year-to-date investments are about $1.9 billion across roughly two dozen transactions at a blended stabilized yield near 8.7%. CareTrust reports a reloaded investment pipeline of around $600 million of near-term opportunities.
CareTrust (NYSE:CTRE) closed two recent transactions totaling approximately $291 million, including a $65 million acquisition of two off-market senior housing communities in Utah (212 assisted living and memory care units) for its SHOP portfolio, and a $226 million initial investment in a 16‑property care home portfolio across England and Scotland under a long-term lease.
Including additional loans and a UK triple-net care home, third-quarter 2026 investments to date are approximately $308 million at a blended stabilized yield of about 7.8%, bringing 2026 year-to-date investment activity to roughly $1.5 billion at a blended stabilized yield of about 8.7%. CareTrust reports a $540 million near-term investment pipeline, mainly skilled nursing acquisitions plus UK care homes and strategic loans.
CareTrust REIT (NYSE:CTRE) reported second quarter 2026 net income of $89.0 million, or $0.38 per diluted share, up $0.03, or 9%, year over year. Normalized FFO was $119.7 million, or $0.51 per share, and Normalized FAD was $118.5 million, or $0.51 per share, each up $0.08, or 19%.
During the quarter, CareTrust closed $899.6 million of investment activity at an 8.9% blended stabilized yield, generated 100% rent and interest collections, and reported Net Debt to Annualized Normalized Run Rate EBITDA of 1.01x. The company settled $363.6 million of ATM forward equity contracts and has $578.2 million of forward equity proceeds still unsettled.
CareTrust increased 2026 guidance to net income of $1.53–$1.56 per share, Normalized FFO of $2.03–$2.06, and Normalized FAD of $2.01–$2.04. The quarterly dividend of $0.39 per share represents about 76% of second quarter 2026 Normalized FFO and FAD.